You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,166,205


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,166,205 protect, and when does it expire?

Patent 10,166,205 protects NAFTIN and is included in one NDA.

This patent has three patent family members in three countries.

Summary for Patent: 10,166,205
Title:Topical compositions and methods for making and using same
Abstract: A gel composition for topical administration that includes: naftifine or a pharmaceutically acceptable salt thereof; a solvent; a non-carbomer rheology modifier; a polysorbate solubilizing agent; and an amine pH adjuster.
Inventor(s): Hardas; Bhushan (Summerville, NC), Dalton; Donna (High Point, NC)
Assignee: SEBELA INTERNATIONAL BERMUDA LIMITED (Hamilton, BM)
Application Number:14/857,232
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,166,205

Introduction

When analyzing a patent, understanding its scope, claims, and the broader patent landscape is crucial for innovators, patent practitioners, and businesses. This article will delve into the details of United States Patent 10,166,205, exploring its claims, the context within which it was granted, and the implications for the patent landscape.

Understanding Patent Claims

Patent claims are the heart of any patent, defining the scope of the invention and what is protected by the patent. The clarity, breadth, and validity of these claims are critical in determining the patent's strength and enforceability[3].

The Patent in Question: 10,166,205

To analyze the scope and claims of United States Patent 10,166,205, we need to examine the patent's specification, claims, and any relevant background.

Patent Specification

The specification of a patent provides a detailed description of the invention, including how it works and its various components. For Patent 10,166,205, the specification would outline the technical details of the invention, such as its purpose, functionality, and any unique features.

Patent Claims

The claims section of the patent is where the inventor defines what is considered the invention. These claims must be clear, concise, and supported by the specification. Here, we would look at the independent and dependent claims to understand the full scope of what is patented.

Claim Construction and Interpretation

Claim construction is a critical step in understanding the patent's scope. This involves interpreting the language of the claims to determine what is covered by the patent. The courts and the USPTO use various rules and guidelines to ensure consistent and fair interpretation[5].

Patent Scope Metrics

Researchers have developed metrics to measure patent scope, such as independent claim length and independent claim count. These metrics can help in assessing the breadth and clarity of the patent claims. For example, narrower claims at publication are often associated with a higher probability of grant and a shorter examination process[3].

Covered Business Method (CBM) Review

In certain cases, patents can be subject to a Covered Business Method (CBM) review under the Leahy-Smith America Invents Act. This review is used to challenge the validity of patents that are directed to performing data processing or other operations used in the practice, administration, or management of a financial product or service. While Patent 10,166,205 may not fall directly under this category, understanding the CBM review process can provide insights into how patents related to data analytics and business methods are scrutinized[1].

AI and Patent Eligibility

Recent updates from the USPTO, such as the 2024 guidance on AI patents, have refined the process for determining the patent eligibility of AI-related inventions. This guidance includes examples of patent-eligible and ineligible claims, which can be useful in evaluating the patentability of inventions involving AI technology. If Patent 10,166,205 involves AI or software-related claims, this guidance would be particularly relevant[5].

Patent Landscape and Trends

Analyzing the patent landscape involves looking at trends in patent filings, grants, and litigation. The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014, which can help in understanding broader trends and how Patent 10,166,205 fits into this landscape[2].

Implications for Innovators and Practitioners

For innovators and patent practitioners, understanding the scope and claims of a patent like 10,166,205 is essential for several reasons:

  • Infringement Avoidance: Knowing what is covered by the patent helps in avoiding potential infringement.
  • Licensing and Collaboration: Clear understanding of the patent's scope can facilitate licensing agreements and collaborative efforts.
  • Litigation Preparation: In the event of litigation, a thorough analysis of the patent claims is crucial for defending or challenging the patent.

Case Studies and Examples

Real-world examples, such as the case of Symphony Health Solutions Corp. v. IMS Health Inc., illustrate how patents related to data analytics can be challenged under CBM review. Such cases provide valuable insights into how the USPTO interprets and applies the rules regarding business method patents[1].

Key Takeaways

  • Clear Claims: The clarity and specificity of patent claims are critical in defining the scope of the invention.
  • Patent Scope Metrics: Metrics like independent claim length and count can help assess the breadth and clarity of patent claims.
  • Regulatory Updates: Recent USPTO guidance on AI patents and CBM reviews can significantly impact the patentability and validity of certain inventions.
  • Landscape Analysis: Understanding broader trends in patent filings and grants can provide context for the significance and potential impact of a patent.

FAQs

Q: What is the importance of claim construction in patent analysis? A: Claim construction is crucial as it determines the scope of what is protected by the patent, affecting infringement, licensing, and litigation.

Q: How does the USPTO's 2024 guidance on AI patents impact software-related inventions? A: The guidance provides clearer rules for determining the patent eligibility of AI-related inventions, helping practitioners draft more robust claims and avoid common rejections.

Q: What is a Covered Business Method (CBM) review, and how does it apply to data analytics patents? A: A CBM review is a process to challenge the validity of patents related to financial product or service operations. It can apply to data analytics patents if they are deemed to fall within this category.

Q: How do metrics like independent claim length and count help in assessing patent scope? A: These metrics provide a quantitative way to measure the breadth and clarity of patent claims, which can predict the likelihood of patent grant and the length of the examination process.

Q: Why is understanding the patent landscape important for innovators and practitioners? A: It helps in identifying trends, avoiding infringement, and making informed decisions about licensing and litigation.

Sources

  1. Healthcare Data Analytics Patent Subject to “CBM” Review at USPTO - Holland & Knight LLP
  2. Patent Claims Research Dataset - USPTO
  3. Patent Claims and Patent Scope - SSRN
  4. Invention, Knowledge Transfer, and Innovation - NCSES
  5. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,166,205

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sebela Ireland Ltd NAFTIN naftifine hydrochloride GEL;TOPICAL 204286-001 Jun 27, 2013 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,166,205

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014212201 ⤷  Subscribe
Canada 2899725 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2014121048 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.